Save time and get answers to complex questions with AI chat
What is the difference between apixaban and apixaban accord?When oxcarbazepine patent expired?Patent expiration eu dabrafenib?Drugpatentwatch skyrizi biologic patent analysis?Drugpatentwatch trametinib?
See the DrugPatentWatch profile for Tremfya
There are no separate biosimilars of Tremfya—Tremfya itself is a biosimilar. The drug is the branded formulation of adalimumab-atto (the first FDA‑approved adalimumab biosimilar). However, there are other adalimumab biosimilars that compete with Tremfya, such as:
Tremfya = Amjevita Tremfya is the brand name for Amgen’s adalimumab‑atto, so when you see Tremfya you are already looking at a biosimilar. The other names above are other biosimilars of the same active ingredient.
If you’re a prescriber or a patient trying to navigate this, checking the most recent formulary and consulting your pharmacist can help you pick the most cost‑effective option without compromising safety or efficacy.
Other Questions About Tremfya :